Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Fengnan Zhi"'
Autor:
Xiuyun Shen, Chunpeng Shi, Jincheng Xu, Fengnan Zhi, Kunpeng Luo, Yuzhu Di, Wanhong Li, Wanjing Ma, Yanan Jiang, Hui Sun
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-12 (2024)
Abstract Alcoholic liver disease (ALD) is a disease with high incidence, limited therapies, and poor prognosis. The present study aims to investigate the effect of riboflavin on ALD and explore its potential therapeutic mechanisms. C57BL/6 mice were
Externí odkaz:
https://doaj.org/article/87891b64c2734845b44df8d1212d164e
Autor:
Yanan Jiang, Xiuyun Shen, Fengnan Zhi, Zhengchao Wen, Yang Gao, Juan Xu, Baofeng Yang, Yunlong Bai
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Arsenic trioxide is a first-line treatment drug for acute promyelocytic leukemia, which is also effective for other kinds of leukemia. Its side effects, however, limit its clinical application, especially for patients with complex leukemia s
Externí odkaz:
https://doaj.org/article/cfe13dea351a4df99f927a8b4b610908
Autor:
Xiuyun Shen, Fengnan Zhi, Chunpeng Shi, Jincheng Xu, Yuqiu Chao, Juan Xu, Yanan Jiang, Yunlong Bai, Baofeng Yang
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background/Aims Arsenic trioxide (ATO) is the first-line therapeutic drug for acute promyelocytic leukemia. However, the cardiotoxicity of ATO limits its clinical application. This study aims to explore the long noncoding RNA (lncRNA) involv
Externí odkaz:
https://doaj.org/article/c8ba8219439b4fabb76fcf43dae40ca2
Publikováno v:
Cardio-Oncology, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Background During cancer treatment, patients have a significantly higher risk of developing cardiovascular complications such as hypertension. In this study, we investigated the internal relationships between hypertension and different types
Externí odkaz:
https://doaj.org/article/0ef388b667a4449eabcd4b522e19926f
Autor:
Xiuyun Shen, Fengnan Zhi, Chunpeng Shi, Jincheng Xu, Yuqiu Chao, Juan Xu, Yanan Jiang, Yunlong Bai, Baofeng Yang
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/7d75fa8f9b9f403296100e4f4344fb84
Autor:
Ying Ma, Dongliang Li, Wenfeng Liu, Xiaoxiao Liu, Yingqi Xu, Xinrui Zhong, Fengnan Zhi, Xueling Jia, Yanan Jiang, Yuhua Fan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background/Aims: Atherosclerosis (AS) is one of the major leading causes of death globally, which is highly correlated with metabolic abnormalities. Resveratrol (REV) exerts beneficial effects on atherosclerosis. Our aim is to clarify the involvement
Externí odkaz:
https://doaj.org/article/f8a3e30ff2104769a6c5b0735b6cc00d
Autor:
Yuzhu Di, Yanan Jiang, Fengnan Zhi, Ying Hu, Ruiling Xu, Jingyang Liu, Lei Zhao, Dandan Ning, Shizhu Jin
Background: Liver fibrosis (LF) is the pathological basis of a majority of chronic liver diseases, characterized by excessive activation of hepatic stellate cells (HSCs), inflammatory disorders and progressive scarring of the hepatic interstitial. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f7ebdf32a33a1d1fd8627613fce5f12
https://doi.org/10.21203/rs.3.rs-2832582/v1
https://doi.org/10.21203/rs.3.rs-2832582/v1
Autor:
Xiaoqi Liu, Zengqiang Wang, Meijiao Liu, Fengnan Zhi, Pengpeng Wang, Xingyu Liu, Shanxiao Yu, Bing Liu, Yanan Jiang
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2022 (2022)
Journal of Oncology, Vol 2022 (2022)
Osteosarcoma remains a major health problem in teenagers. However, its pathogenesis mechanism remains not fully elucidated. This study aims to identify the prognostic biomarkers for osteosarcoma. In this study, we selected genes with a median absolut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f1aa78df5948ecdfe4115fa6237d3f
Autor:
Hai Feng, Lu Chai, Shucai Yang, Yanan Jiang, Yue Ou, Ying Liu, Moyondafoluwa Blessing Fasae, Siwei Liu, Xiuyun Shen, Fengnan Zhi
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Hepatocellular carcinoma (HCC) is among the most common and lethal form of cancer worldwide. However, its diagnosis and treatment are still dissatisfactory, due to limitations in the understanding of its pathogenic mechanism. Therefore, it is importa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bacf75a184233852933e193ee3f64c1f
http://europepmc.org/articles/PMC8541861
http://europepmc.org/articles/PMC8541861
Autor:
Xueling Jia, Yingqi Xu, Xinrui Zhong, Ying Ma, Yuhua Fan, Wenfeng Liu, Xiaoxiao Liu, Fengnan Zhi, Dongliang Li, Yanan Jiang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background/Aims: Atherosclerosis (AS) is one of the major leading causes of death globally, which is highly correlated with metabolic abnormalities. Resveratrol (REV) exerts beneficial effects on atherosclerosis. Our aim is to clarify the involvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b7812779e4bf1a67ae5cc5b2be7ffd
https://www.frontiersin.org/articles/10.3389/fphar.2021.747625/full
https://www.frontiersin.org/articles/10.3389/fphar.2021.747625/full